Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-30
2007-01-30
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S001110
Reexamination Certificate
active
10491618
ABSTRACT:
The present invention provides an azulene derivative and a salt thereof, wherein an azulene ring is bonded to a benzene ring directly or via a lower alkylene which may be substituted with a halogen atom and the benzene ring is directly bonded to the glucose residue, and it is usable as a Na+-glucose cotransporter inhibitor, especially for a therapeutic and/or preventive agent for diabetes such as insulin-dependent diabetes (type 1 diabetes) and insulin-independent diabetes (type 2 diabetes), as well as diabetes-related diseases such as insulin-resistant diseases and obesity.
REFERENCES:
patent: 6515117 (2003-02-01), Ellsworth et al.
patent: 2001/0041674 (2001-11-01), Tomiyama et al.
patent: WO 98/31697 (1998-07-01), None
patent: WO 01/27128 (2001-04-01), None
patent: WO 02/083066 (2002-10-01), None
patent: WO 03/099836 (2003-12-01), None
Ikegai Kazuhiro
Imamura Masakazu
Kitta Kayoko
Kobayashi Yoshinori
Kurosaki Eiji
Astellas Pharma Inc.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Jiang Shaojia Anna
Kotobuki Pharmaceutical Co. Ltd.
McIntosh Traviss
LandOfFree
Azulene derivatives and salts thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azulene derivatives and salts thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azulene derivatives and salts thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776056